Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Jantratid, E."'
Autor:
Strauch, S., Jantratid, E. *, Dressman, J.B., Junginger, H.E., Kopp, S., Midha, K.K., Shah, V.P., Stavchansky, S., Barends, D.M.
Publikováno v:
In Journal of Pharmaceutical Sciences January 2011 100(1):11-21
Autor:
Jantratid, E., Strauch, S., Becker, C., Dressman, J.B., Amidon, G.L., Junginger, H.E., Kopp, S., Midha, K.K., Shah, V.P., Stavchansky, S., Barends, D.M. *
Publikováno v:
In Journal of Pharmaceutical Sciences April 2010 99(4):1639-1653
Publikováno v:
Songklanakarin Journal of Science and Technology (SJST), Vol 35, Iss 1, Pp 41-50 (2013)
Scopus-Elsevier
Scopus-Elsevier
Determination of atorvastatin in human plasma using LC-MS/MS has been widely accepted as an effective methodowing to its practical applicability in routine drug analysis in pharmacokinetic and pharmacogenetic study. Nevertheless, themethod sensitivit
For predicting food effects and simulating plasma profiles of poorly soluble drugs, physiologically based pharmacokinetic models have become a widely accepted tool in academia and the pharmaceutical industry. Up till now, however, simulations appeari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1f7f4a94dc93ac913cefe3405ac8458c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3061412
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3061412
The ability of in vitro biorelevant dissolution tests to predict the in vivo performance of nanosized fenofibrate (Lipidil 145 ONE®) and microsized fenofibrate (Lipidil - Ter®) was evaluated in this study. In vitro dissolution was carried out using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1b515dccb918fafd1bd335dc7a8fac3d
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3061769
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3061769
This study coupled results from biorelevant dissolution tests with in silico simulation technology to forecast in vivo oral absorption of micronized and nanosized aprepitant formulations in the pre- and post-prandial states. In vitro dissolution test
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::290c607ab2b0657eb1139bfbbba3bd20
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3061858
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3061858
In vitro biorelevant dissolution tests enabling the prediction of in vivo performance of an oral modified-release (MR) dosage form were developed in this study. In vitro dissolution of MR diclofenac sodium pellets containing 100 mg active ingredient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e8e041e0525ba27a7d0a2ee1938f512e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3062107
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3062107
Autor:
Shono, Y. Jantratid, E. Janssen, N. Kesisoglou, F. Mao, Y. Vertzoni, M. Reppas, C. Dressman, J.B.
Since the rate-determining step to the intestinal absorption of poorly soluble drugs is the dissolution in the gastrointestinal (GI) tract, postprandial changes in GI physiology, in addition to any specific interactions between drug and food, are exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::adb14c9cdbe35302afbe19b12a524eb9
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3062060
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3062060
Autor:
Strauch, S., Jantratid, E., Dressman, J.B., Junginger, H.E., Kopp, S., Midha, K.K., Shah, V.P., Stavchansky, S., Barends, D.M. *
Publikováno v:
In Journal of Pharmaceutical Sciences June 2011 100(6):2054-2063
Purpose. The aim of this study was to update the compositions of biorelevant media to represent the composition and physical chemical characteristics of the gastrointestinal fluids as closely as possible while providing physical stability during diss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::6f03acc9aae73568f8ca92cc1199d1d7
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3062360
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3062360